Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
09/1996
09/11/1996CN1130909A 5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
09/11/1996CA2170968A1 Preparation of d4t from 5-methyluridine
09/10/1996CA2036507C 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions
09/04/1996EP0729971A1 Method for the preparation of Ivermectin
09/04/1996EP0729515A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
09/04/1996EP0623174B1 Homocysteine assay
09/04/1996EP0355131B1 Acyl deoxyribonucleoside derivatives and uses thereof
09/03/1996US5552540 Nonradioactive labels
09/03/1996US5552538 Oligonucleotides with cleavable sites
09/03/1996US5552387 Polycyclic ether antibiotics
09/03/1996US5552386 Compounds for bactericides or antiprotozoa agents
09/03/1996US5552311 Purine nucleoside phosphorylase gene therapy for human malignancy
08/1996
08/28/1996EP0728204A1 Base-modified enzymatic nucleic acid
08/28/1996EP0728139A1 Amine-derivatized nucleosides and oligonucleosides
08/28/1996EP0523100B1 O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing o6 -alkylguanine-dna alkyltransferase depleting activity
08/28/1996EP0420872B1 Therapeutic uses of 2',5'-oligoadenylate derivatives
08/28/1996CN1129700A Extraction and application of Lobed Kudzuvine
08/27/1996US5550155 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures
08/27/1996US5550132 Treating septic shock, cachexia, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, aids
08/22/1996WO1996025421A1 Specific lipid conjugates of nucleoside diphosphates and their use as drugs
08/22/1996WO1996018634A3 Nucleoside derivatives with photolabile protective groups
08/22/1996DE19505168A1 Spezifische Lipidkonjugate von Nucleosid-Diphosphonaten und deren Verwendung als Arzneimittel Specific lipid conjugates of nucleoside diphosphonates and their use as medicaments
08/22/1996CA2212877A1 Specific lipid conjugates of nucleoside diphosphates and their use as drugs
08/21/1996EP0727433A1 Process for the preparation of 1-(2'-deoxy-2',2'-difluoro-d-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-beta-d-ribo-pentopyranose
08/21/1996EP0726904A1 5-fluorouracil derivatives
08/21/1996CN1129453A Thermodynamically stable crystal form of 4"-Deoxy-4"-epi-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation
08/20/1996US5547941 Cyclic dinucleoside diphosphorothioates, related compounds and pharmaceutical compositions
08/20/1996US5547860 Enzymatic incorporation into nucleic acids; detection by hybridization
08/20/1996US5547859 Chain-terminating nucleotides for DNA sequencing methods
08/20/1996US5547839 Contacting polynucleotides with surface of solid substrate, hybridizing using nucleic acid polymerase and labeled nucleotide
08/20/1996US5547835 Using the sanger sequencing strategy and assembling the sequence information by analysis of the nested fragments obtained by base-specific chain termination via their different molecular masses
08/20/1996US5547667 Linker for bioactive agents
08/20/1996CA1338532C 2',3'-dideoxy purine nucleosides and process for the preparation thereof
08/15/1996WO1996024690A1 Electrogenerated chemiluminescence labels for analysis and/or referencing
08/14/1996EP0726322A1 Homocysteine assay
08/14/1996EP0725788A1 2'-amido and 2'-peptido modified oligonucleotides
08/14/1996EP0725787A1 Activated nucleoside phosphoramidites and methods for the preparation and use thereof
08/14/1996EP0725782A1 Novel a 1 adenosine receptor agonists and antiagonists
08/13/1996US5545730 Multifunctional nucleic acid monomer
08/13/1996US5545627 Irreversible inhibitors of adenosine receptors
08/08/1996WO1996023808A1 Improved methods for h-phosphonate synthesis of oligonucleotides
08/08/1996WO1996023807A1 Novel chain terminators, the use thereof for nucleic acid sequencing and synthesis and a method of their preparation
08/08/1996WO1996023806A1 Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides
08/08/1996WO1996023509A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
08/08/1996WO1996023506A1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment and medicaments containing said nucleosides
08/08/1996CA2212000A1 Novel chain terminators, the use thereof for nucleic acid sequencing and synthesis and a method of their preparation
08/08/1996CA2211973A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
08/07/1996EP0724647A1 Nucleic acid ligands and improved methods for producing the same
08/07/1996EP0724587A1 Ring-expanded nucleosides and nucleotides
08/07/1996CN1128270A Synthetic method of arabinosyladenosine
08/07/1996CN1128269A Oligoribonucleotides with amide backbone
08/06/1996US5543510 2,3,5-tri-o-protecting group substituted-1-bromo-b-ribofuranosyl amide enantiomorphs for stereospecific production of herbicide
08/06/1996US5543391 Covalent microparticle-drug conjugates for biological targeting
08/06/1996US5543390 Comprising a biologically-active compound including an antimicrobial drug. a microparticle and a cleavable linker moiety
08/06/1996US5543389 Ointment containing antiproliferative drug bound to lipid carrier through linking and spacer groups, for rapid efficient drug delivery in treatment of skin disorders
08/06/1996US5543293 Using selex (systematic evolution of ligands for exponential enrichment) for indentification; mixing candiate dna's with thrombin;partioning and amplification of those with high affinity; anticoagulant; stability in vivo
08/01/1996WO1996022778A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/01/1996CA2546745A1 Nucleosides with [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
07/1996
07/30/1996US5541345 Anomeric fluororibosyl amines
07/30/1996US5541341 Nonionic glycasuccinimide surfactants and a process for their manufacture
07/30/1996US5541313 Single-stranded labelled oligonucleotides of preselected sequence
07/30/1996US5541307 Backbone modified oligonucleotide analogs and solid phase synthesis thereof
07/30/1996US5541193 Organ transplants
07/30/1996US5541164 Such as cladribine, to treat e.g. rheumatoid arthritis and multiple sclerosis
07/30/1996CA1338491C Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
07/25/1996WO1996022383A1 Spectroscopically detectable nucleic acid ligands
07/25/1996WO1996022303A1 Therapeutic compound - fatty acid conjugates
07/25/1996WO1996022300A1 THERMODYNAMICALLY STABLE CRYSTAL FORM OF 4'-DEOXY-4'-EPI-METHYLAMINO AVERMECTIN B1a/B1b BENZOIC ACID SALT AND PROCESSES FOR ITS PREPARATION
07/25/1996WO1996022298A1 Method and composition for stabilization of labelled nucleoside triphosphates
07/25/1996CA2210500A1 Therapeutic compound - fatty acid conjugates
07/24/1996EP0722734A1 NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration
07/24/1996EP0722453A1 Process and antiparasitic intermediates for doramectin
07/24/1996CN1127301A A method for the resolution of a racemic mixture of nucleoside enantioners
07/23/1996US5539116 Method and compositions for the synthesis of BCH-189 and related compounds
07/23/1996US5539099 Process for large-scale preparation of 2',3'-didehydro-2',3'-dideoxynucleosides
07/23/1996US5539098 5'-O-propionyl and 5'-O-butyryl esters of 2-amino-6-methoxy-9-(β-D-arabinofuranosyl)-9H-purine
07/23/1996US5538975 (-)-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5yl) -(1h)-pyrimidin-2-one and derivatives; antiviral agent
07/23/1996CA2012095C 3'-tosylcytidine compounds and process for production thereof
07/23/1996CA2012094C Process for producing cytarabine and analogues thereof
07/23/1996CA2004752C Pyrimidine 2'-methylidene nucleoside compounds
07/18/1996CA2735293A1 Nadh and nadph therapeutic agents for dermal administration
07/18/1996CA2167104A1 Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration
07/17/1996EP0721955A2 Diadenosine tetraphosphate tetrasodium salt dodecahydrate crystals
07/17/1996EP0721511A1 Method of preparing arabinonucleotides
07/17/1996EP0711301A4 Processes and intermediates for phosphorous-containing covalent linkages
07/17/1996CN1126726A Process for N-acyl-5-fluorocytidine derivatives
07/16/1996US5536827 Antitumor
07/16/1996US5536824 Organosulfonyl salts of 2,3'-O-cyclocytidine
07/16/1996US5536823 3'-sulfonyl nucleoside compounds
07/11/1996WO1996020946A1 Flavin adenine dinucleotide analogues, their pharmaceutical compositions, and their activity as monoamine oxidase inhibitors
07/11/1996WO1996020939A1 POLYMORPHS B AND C OF 1-[2,4-DICHLORO-β-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE
07/11/1996WO1996020711A1 Drugs to prevent recurrent herpes virus infections
07/11/1996WO1996012508A3 Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy
07/10/1996EP0720604A1 Conformationally locked nucleoside analogues
07/10/1996CN1032258C Process for preparacing phospholpid derivatives of nucleosides
07/09/1996US5534632 Macrocyclic carbamate immunomodulators
07/09/1996US5534504 Treating myocardial infarction by administration of a thrombolytic agent together with adenosine
07/09/1996US5534503 2'-O, N6 -disubstituted and 2'-O, N6, 2-trisubstituted adenosines and their medicinal uses
07/04/1996WO1996020011A1 Chemical compounds
07/04/1996CA2205091A1 Chemical compounds